Matinas BioPharma Holdings, Inc. (MTNB) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Matinas BioPharma Holdings, Inc. (MTNB) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

MTNB Cash Flow Statement

Matinas BioPharma Holdings, Inc. (MTNB) cash flow statement — 14-year operating, investing & financing cash flows

Annual Quarterly

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Cash from Operations	-1.84M	-1.6M	-1.51M	-1.47M	-2.02M	-2.01M	-3.51M	-3.5M	-3.11M	-5.77M	-4.58M	-4.42M	-2.19M	-4.09M	-4.3M	-4.97M	-5.13M	-4.76M	-3.96M	-5.75M
Operating CF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-372.9%	-404.46%	-467.54%	-482.69%	-	1188503.6%	-
Operating CF Growth %	9.15%	20.23%	57.01%	57.89%	34.93%	65.21%	23.35%	20.8%	-41.63%	-41.15%	-6.5%	11.09%	57.26%	14.06%	-8.63%	13.56%	-493.42%	-2.25%	8.12%	-10.01%
Net Income	-1.33M	-1.92M	-1.91M	-1.53M	-5.25M	-1.66M	-8.43M	-4.28M	-5.72M	-5.82M	-5.31M	-6.05M	-6.06M	-5.51M	-3.63M	-5.46M	-5.92M	-5.98M	-6.7M	-6.84M
Depreciation & Amortization	4K	74K	423K	114K	124K	128K	247K	243K	241K	240K	240K	238K	234K	229K	225.82K	230K	231K	211.53K	205.11K	196.04K
Stock-Based Compensation	104K	0	217K	253K	238K	315K	244K	965K	991K	995K	1.27M	1.2M	1.21M	1.27M	0	1.41M	1.22M	0	1.07M	1.06M
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Cash Items	-627K	113K	-14K	-3K	3.34M	-294K	4.35M	4K	-37K	18K	18K	17K	29K	44K	1.4M	48K	49K	1.61M	80.43K	1.26M
Working Capital Changes	9K	133K	-223K	-306K	-481K	-500K	86K	-437K	1.42M	-1.2M	-795K	185K	2.4M	-119K	-2.29M	-1.2M	-703K	-600.99K	1.38M	-1.43M
Change in Receivables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Payables	132K	397K	235K	-86K	-116K	187K	-254K	111K	-235K	-41K	-320K	230K	89K	-102K	-39.45K	159K	-855K	413.63K	276.27K	211.54K
Cash from Investing	0	0	15K	320K	0	0	500K	9.65M	-2.94M	2M	2.96M	1.08M	6.2M	3M	-42.01K	5.75M	-3.79M	2.96M	56.67K	242.69K
Capital Expenditures	0	0	0	0	0	0	0	0	0	0	0	-16K	-202K	0	-41.6K	-250K	-55K	-544.56K	-36.19K	-224.19K
CapEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3.91%	23.52%	5.17%	-	-10868.47%	-
Acquisitions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	15K	320K	0	0	0	7.94M	-7.94M	0	0	0	0	0	0	0	0	0	0	0
Cash from Financing	-1K	0	58K	64K	1.62M	1.65M	-1K	-67K	9.19M	53K	-1K	-1K	-1K	-4K	-4.64K	-3K	-6K	92.92K	8.09K	-8.32K
Debt Issued (Net)	-1K	0	-7K	0	-1K	-1K	-1K	-2K	-1K	-1K	-1K	-1K	-1K	-4K	-4.2K	-3K	-6K	-6.53K	-6.39K	-8.32K
Equity Issued (Net)	0	0	65K	64K	1.65M	1.65M	0	-65K	9.19M	54K	0	0	0	0	-441	0	0	99.44K	14.48K	-1
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Financing	0	0	0	0	-27K	-2K	0	0	0	0	0	0	0	0	0	0	0	0	0	1
Net Change in Cash	-1.84M	-1.6M	-1.44M	-1.09M	-399K	-360K	-3.01M	6.08M	3.15M	-3.72M	-1.62M	-3.34M	4M	-1.09M	-4.35M	777K	-8.93M	-1.7M	-3.89M	-5.52M
Free Cash Flow	-1.84M	-1.6M	-1.51M	-1.47M	-2.02M	-2.01M	-3.51M	-3.5M	-3.11M	-5.77M	-4.58M	-4.43M	-2.4M	-4.09M	-4.34M	-5.22M	-5.19M	-5.3M	-3.99M	-5.97M
FCF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-372.9%	-408.37%	-491.06%	-487.86%	-	1199372.37%	-
FCF Growth %	9.15%	20.23%	57.01%	57.89%	34.93%	65.21%	23.35%	21.08%	-29.69%	-41.15%	-5.48%	15.04%	53.82%	22.89%	-8.69%	12.62%	-499.77%	-13.96%	7.16%	-14.3%
FCF per Share	-4.30	-3.75	-4.13	-4.07	-5.96	-5.92	-10.82	-10.42	-9.34	-19.91	-1.05	-1.02	-0.55	-0.94	-1.00	-1.20	-1.20	-1.22	-0.92	-1.39
FCF Conversion (FCF/Net Income)	1.38x	0.83x	0.79x	0.69x	0.39x	1.21x	0.42x	0.82x	0.54x	0.99x	0.86x	0.73x	0.36x	0.74x	1.18x	0.91x	0.87x	0.80x	0.59x	0.84x
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0